Rigorous analysis suggested that the ADAM12 p.L792F mutant was comparable to WT ADAM12 in every aspects analyzed, indicating that the di-leucine motif was not involved in the intracellular trafficking of ADAM12 and thus may not be contributing significantly to the breast cancer phenotype. The gene discussed is ADAM12; the disease is breast carcinoma.